Page 85 - Eshre 2018
P. 85
Genome engineering through CRISPR/Cas9 technology in the human germline and preimplantation embryos
Rita Vassena
Scientific Director EUGIN Group
Declaration of interests
I do not have any comercial interest related to the content of this talk
Page 79 of 130
PRECONGRESS COURSE 01 I BARCELONA, SPAIN – 1 JULY 2018 85
